BACHEM PIONEERING PARTNER FOR PEPTIDES Trademark

Trademark Overview


On Tuesday, April 8, 2014, a trademark application was filed for BACHEM PIONEERING PARTNER FOR PEPTIDES with the United States Patent and Trademark Office. The USPTO has given the BACHEM PIONEERING PARTNER FOR PEPTIDES trademark a serial number of 79147352. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, April 8, 2024. This trademark is owned by Bachem Holding AG. The BACHEM PIONEERING PARTNER FOR PEPTIDES trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical and veterinary products, namely, pharmaceutical preparations for use in the treatment of bleeding, premature labor, pulmonary hypertension, erectile disfunction, coronary syndromes, prostate cancer, endometriosis, central precocious puberty, uterine myoma, osteoporosis, hypercalcernia, Paget's disease, reflex sympathetic dystrophy, nocturnal enureses, central diabetes insipidus, polyuria, polydipsia, hemophilia A, von Willebrand disease, unstable angina, myocardial infarction, hypoglycemia, ovarian follicular cysts, cryptochism, breast cancer, growth hormone deficiency, acromegaly, carcinoid syndrome, thyrotrophic adenomas, diabetes II, VIPosmas, ulcer bleeding, hemorrhagic gastritis, postoperative pancreatic and duodenal fistulae, variceal hemorrhage, neurological diseases, rheumatic diseases, skin diseases, diseases of the intestinal tract, cancer, conjunctivitis, glaucoma, ocular hypertension, Parkinson's disease, transfusion-induced hemosiderosis, candidasis, dermato...

Chemicals for use in industry and science, namely, amino acids, peptides, reagents for peptide synthesis, amino acid derivatives, cytokines, enzyme inhibitors, enzyme substrates, growth factors, peptide substrates, all for use as scientific and laboratory research reagents in the field of medicine and molecular biology; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; chemical products used for preserving foodstuffs
bachem pioneering partner for peptides

General Information


Serial Number79147352
Word MarkBACHEM PIONEERING PARTNER FOR PEPTIDES
Filing DateTuesday, April 8, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, April 8, 2024
Registration Number4741293
Registration DateTuesday, May 26, 2015
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 10, 2015

Trademark Statements


Description of MarkThe mark consists of the wording "BACHEM" in stylized form above the wording "PIONEERING PARTNER FOR PEPTIDES" in stylized form.
Goods and ServicesPharmaceutical and veterinary products, namely, pharmaceutical preparations for use in the treatment of bleeding, premature labor, pulmonary hypertension, erectile disfunction, coronary syndromes, prostate cancer, endometriosis, central precocious puberty, uterine myoma, osteoporosis, hypercalcernia, Paget's disease, reflex sympathetic dystrophy, nocturnal enureses, central diabetes insipidus, polyuria, polydipsia, hemophilia A, von Willebrand disease, unstable angina, myocardial infarction, hypoglycemia, ovarian follicular cysts, cryptochism, breast cancer, growth hormone deficiency, acromegaly, carcinoid syndrome, thyrotrophic adenomas, diabetes II, VIPosmas, ulcer bleeding, hemorrhagic gastritis, postoperative pancreatic and duodenal fistulae, variceal hemorrhage, neurological diseases, rheumatic diseases, skin diseases, diseases of the intestinal tract, cancer, conjunctivitis, glaucoma, ocular hypertension, Parkinson's disease, transfusion-induced hemosiderosis, candidasis, dermatophytosis, pityriasis, congenital homocystinuria, hyperammonaemia, hepatic encephalopathy, ischemic heart disease, chorioretinal vascular disorders, hypertension, endema, insomnia, bipolar disorder, and schizophrenia; pharmaceutical preparations for use in the diagnosis of gastrinoma; veterinary preparations for use in the induction of ovulation in estrous mares, and reproduction control in dogs and cats; pharmaceutical preparations for use in the diagnosis of Cushing's syndrome, hypothalamic-pituitary-gonadal axis function, growth hormone deficiency, pancreatic exocrine dysfunction, gastrinoma, and adrenocortical insufficiency; dietetic food and substances for medical or veterinary use, namely, taste-modulating food additives in the nature of peptides for medical use, appetite suppressors for medical use; food supplements for humans and animals; fungicides; herbicides
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesChemicals for use in industry and science, namely, amino acids, peptides, reagents for peptide synthesis, amino acid derivatives, cytokines, enzyme inhibitors, enzyme substrates, growth factors, peptide substrates, all for use as scientific and laboratory research reagents in the field of medicine and molecular biology; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; chemical products used for preserving foodstuffs

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 10, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBachem Holding AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameBachem Holding AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameBachem Holding AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Friday, May 30, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 18, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, May 29, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, June 3, 2014APPLICATION FILING RECEIPT MAILED
Thursday, July 17, 2014ASSIGNED TO EXAMINER
Thursday, July 17, 2014NON-FINAL ACTION WRITTEN
Wednesday, July 23, 2014REFUSAL PROCESSED BY MPU
Wednesday, July 23, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 8, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 8, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 9, 2015EXAMINER'S AMENDMENT ENTERED
Friday, August 8, 2014REFUSAL PROCESSED BY IB
Thursday, January 8, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 9, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, January 9, 2015EXAMINERS AMENDMENT E-MAILED
Friday, January 9, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 9, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 29, 2015ASSIGNED TO LIE
Wednesday, February 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 18, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 18, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 10, 2015PUBLISHED FOR OPPOSITION
Tuesday, March 10, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 26, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, August 26, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, January 30, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 6, 2015NOTIFICATION PROCESSED BY IB
Thursday, September 24, 2015FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 24, 2015FINAL DISPOSITION PROCESSED
Friday, October 30, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 1, 2019NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, May 26, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, December 10, 2021CANCELLED SECTION 71
Thursday, September 22, 2022INVALIDATION PROCESSED
Wednesday, August 10, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, September 22, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, October 24, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Friday, November 1, 2024DEATH OF INTERNATIONAL REGISTRATION
Friday, November 1, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED